Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
John R Desjarlais
23 Jan 2026
Sr. Vice President & CSO
Exercised, kept
5,322
$12.51
$66.58K
Bassil I Dahiyat
22 Dec 2025
President & CEO
Exercised, kept
10,624
$12.51
$132.91K
John R Desjarlais
22 Dec 2025
Sr. Vice President & CSO
Exercised, kept
6,311
$12.51
$78.95K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 2
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 452,753
History held since 6 Dec 2013